Ignite Creation Date:
2025-12-24 @ 2:14 PM
Ignite Modification Date:
2026-01-02 @ 10:11 AM
Study NCT ID:
NCT07130695
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-12-18
First Post:
2025-08-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Olutasidenib Single Plus Combo Therapy in IDH1mut AML After Induction and Consolidation
Sponsor:
Virginia Commonwealth University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-02-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-10-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-10-31
Completion Date Type:
ESTIMATED
First Submit Date:
2025-08-07
First Submit QC Date:
None
Study First Post Date:
2025-08-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-10
Last Update Post Date:
2025-12-18
Last Update Post Date Type:
ESTIMATED